A randomized, open label, multicentre, phase 3 trial to assess the safety of Tobramycin Inhalation Powder compared to TOBI in cystic fibrosis subjects - TIP003 A randomized, open label, multicentre, phase 3 trial to assess the safety of Tobramycin Inhalation P ...
A randomized, open label, multicentre, phase 3 trial to assess the safety of Tobramycin Inhalation Powder compared to TOBI in cystic fibrosis subjects - TIP003 A randomized, open label, multicentre, phase 3 trial to assess the safety of Tobramycin Inhalation P ...
Cystic Fibrosis with presence of Pseudomonas aeruginosa infection MedDRA version: 6.1;Level: PT;Classification code 10011763 Cystic Fibrosis with presence of Pseudomonas aeruginosa infection MedDRA version: 6.1;Level: PT;Clas ...
INN or Proposed INN: Tobramycin Product Name: Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler Product Code: T-326 INN or Proposed INN: TobramycinINN or Proposed INN: Tobramycin Product Name: TobramycinInhalation Powder TIP delivered by the T-326I ...